NCAM1 and cancer: Regarding the low-frequency monocyte subsets mentioned above, IFN-α is known to activate CD56+ monocytes to infiltrate into the tumor and lyse cancer cells through the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway and via T cell activation [11].